影响接受细胞减灭术联合热灌注腹腔化疗治疗孤立性结直肠癌腹膜转移患者生存的预后因素：一项系统评价和荟萃分析。 - Suppr | 超能文献

Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: A systematic review and meta-analysis.

作者信息

van Ramshorst Gabrielle

出版信息

Colorectal Dis. 2020 Nov;22(11):1480. doi: 10.1111/codi.15411.

DOI:10.1111/codi.15411

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: A systematic review and meta-analysis.影响接受细胞减灭术联合热灌注腹腔化疗治疗孤立性结直肠癌腹膜转移患者生存的预后因素：一项系统评价和荟萃分析。

Colorectal Dis. 2020 Nov;22(11):1480. doi: 10.1111/codi.15411.

2

Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis.影响细胞减灭术联合腹腔热灌注化疗治疗孤立性结直肠腹膜转移患者生存的预后因素：系统评价和荟萃分析。

Colorectal Dis. 2020 Nov;22(11):1482-1495. doi: 10.1111/codi.15003. Epub 2020 Feb 27.

3

Research Perspective on Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.同步肝切除、细胞减灭术及热灌注化疗治疗结直肠癌肝转移和腹膜转移的研究现状：一项系统评价和Meta分析

Dis Colon Rectum. 2021 Jun 1;64(6):765. doi: 10.1097/DCR.0000000000002097.

4

Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.结直肠腹膜转移的细胞减灭术和腹腔热灌注化疗的演变：8 年单中心经验。

Dis Colon Rectum. 2019 Oct;62(10):1195-1203. doi: 10.1097/DCR.0000000000001456.

5

Research Perspective on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review.结直肠癌腹膜转移的细胞减灭术和腹腔内热灌注化疗的研究视角：一项系统评价

Dis Colon Rectum. 2022 Jan 1;65(1):27. doi: 10.1097/DCR.0000000000002316.

6

ASO Author Reflections: Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).ASO作者反思：微卫星和RAS/RAF突变状态作为接受减瘤手术和腹腔内热灌注化疗（HIPEC）治疗的结直肠癌腹膜转移的预后因素

Ann Surg Oncol. 2022 Jun;29(6):3418-3419. doi: 10.1245/s10434-021-11057-z. Epub 2021 Nov 6.

7

Early Postoperative Intraperitoneal Versus Hyperthermic Intraperitoneal Chemotherapy After Optimal Cytoreductive Surgery for Colorectal Cancer with Isolated Peritoneal Metastasis (ICARuS).针对伴有孤立性腹膜转移的结直肠癌进行最佳细胞减灭术后早期腹腔内化疗与热灌注腹腔内化疗（ICARuS研究）。

Ann Surg Oncol. 2021 Aug;28(8):4100-4101. doi: 10.1245/s10434-021-10110-1. Epub 2021 May 25.

8

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?细胞减灭术和腹腔热灌注化疗治疗结直肠腹膜转移：我们处于什么位置？

Cancer. 2023 Feb 15;129(4):495-502. doi: 10.1002/cncr.34567. Epub 2022 Dec 16.

9

ASO Author Reflections: Significance of Primary Tumor Location and Genomic Alterations in Colorectal Peritoneal Metastases and Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy.ASO作者反思：原发性肿瘤位置和基因组改变在结直肠癌腹膜转移及细胞减灭术-热灌注化疗中的意义

Ann Surg Oncol. 2023 Jul;30(7):4471-4472. doi: 10.1245/s10434-023-13522-3. Epub 2023 Apr 27.

10

Novel prognostic score for outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with metachronous peritoneal carcinomatosis.结直肠癌伴异时性腹膜转移患者细胞减灭术和腹腔热灌注化疗后结局的新型预后评分。

ANZ J Surg. 2020 Oct;90(10):1958-1964. doi: 10.1111/ans.15783. Epub 2020 Mar 11.